Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

NCT00037804 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00037804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00037804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Completed
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy, liver dysfunction, neoplasms, solid tumor, unspecified adult solid tumor